PROVIDER PROFILE · NPI 1588741078

Robert James Babuji

Internal MedicineWenatchee, WAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

1,107

Beneficiaries

—

Total drug cost

$47K

Distinct drugs

Brand share

11.3%

Top prescribed drugs

Rosuvastatin Calcium82 claims

Losartan Potassium76 claims

Levothyroxine Sodium73 claims

Amlodipine Besylate67 claims

Lisinopril63 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$72

Payment records

By payment type

Food and Beverage$72

Top paying entities

Food and Beverage$72

REFERRAL NETWORK

Where Robert James Babuji's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 34 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
NPI 1275523201	303	1,248
Jiaul Ahsan Internal Medicine · Arlington, TX	199	643
ACCURATE LAB SERVICES, LLC.	129	486
Laboratory Corporation Of America Clinical Laboratory · Dallas, TX	99	262
KOREAN HOME HEALTH CARE INC	99	604
Angelina Rivero Obstetrics & Gynecology · Mesquite, TX	91	261
Dee Martinez Diagnostic Radiology · Dallas, TX	64	160
BAYLOR UNIVERSITY MEDICAL CENTER	61	142
ATOSSA GENETICS INC	46	78
NPI 1114926631	37	133
AMAZING & BLESSED HOME HEALTH SERVICES INC	35	42
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS	32	113

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history